ReShape Lifesciences Inc.
RSLS
$0.365
-$0.015-3.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.13M | -7.07M | -9.02M | -10.92M | -11.39M |
| Total Depreciation and Amortization | 22.00K | 24.00K | 69.00K | 112.00K | 154.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 293.00K | -108.00K | 552.00K | 468.00K | -1.59M |
| Change in Net Operating Assets | 2.39M | 954.00K | -267.00K | -3.63M | -4.13M |
| Cash from Operations | -4.43M | -6.20M | -8.67M | -13.97M | -16.96M |
| Capital Expenditure | -- | 0.00 | 0.00 | -36.00K | -43.00K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 33.00K | 33.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 0.00 | -3.00K | -10.00K |
| Total Debt Issued | 653.00K | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 24.00K | 5.15M | 5.15M | 7.37M | 17.57M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 338.00K | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 677.00K | 5.49M | 5.15M | 7.37M | 17.57M |
| Foreign Exchange rate Adjustments | -16.00K | 6.00K | 5.00K | -3.00K | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.77M | -706.00K | -3.51M | -6.60M | 604.00K |